CAD 0.19
(18.75%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -26.39 Thousand CAD | 11.43% |
2022 | -29.8 Thousand CAD | -112.34% |
2021 | 241.48 Thousand CAD | 301.79% |
2020 | 60.1 Thousand CAD | 0.0% |
2019 | - CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | - CAD | 100.0% |
2023 Q3 | -6574.00 CAD | 0.0% |
2023 Q2 | -6574.00 CAD | 0.74% |
2023 Q1 | -6623.00 CAD | 4.92% |
2023 Q4 | -6623.00 CAD | -0.75% |
2022 Q3 | -6630.00 CAD | 12.74% |
2022 Q2 | -7598.00 CAD | 11.71% |
2022 Q1 | -8606.00 CAD | -114.78% |
2022 FY | -29.8 Thousand CAD | -112.34% |
2022 Q4 | -6966.00 CAD | -5.07% |
2021 Q4 | 58.22 Thousand CAD | 19.52% |
2021 Q3 | 48.71 Thousand CAD | 112.58% |
2021 Q2 | -387.26 Thousand CAD | 10.22% |
2021 FY | 241.48 Thousand CAD | 301.79% |
2021 Q1 | -431.32 Thousand CAD | 0.0% |
2020 Q3 | 13.99 Thousand CAD | 456.16% |
2020 Q2 | 2516.00 CAD | 0.0% |
2020 FY | 60.1 Thousand CAD | 0.0% |
2019 FY | - CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -50.39 Thousand CAD | 47.629% |
Asep Medical Holdings Inc | -113.74 Thousand CAD | 76.794% |
BetterLife Pharma Inc. | - CAD | Infinity% |
BioVaxys Technology Corp. | - CAD | Infinity% |
ChitogenX Inc. | -42 Thousand CAD | 37.157% |
Rapid Dose Therapeutics Corp. | 563.4 Thousand CAD | 104.685% |
Defence Therapeutics Inc. | -90.92 Thousand CAD | 70.971% |
Entheon Biomedical Corp. | 250.32 Thousand CAD | 110.544% |
Gemina Laboratories Ltd. | -93.36 Thousand CAD | 71.731% |
Glow Lifetech Corp. | -505.62 Thousand CAD | 94.78% |
Pharmala Biotech Holdings Inc. | 454.09 Thousand CAD | 105.812% |
Doseology Sciences Inc. | -36.08 Thousand CAD | 26.854% |
MYND Life Sciences Inc. | -332.99 Thousand CAD | 92.074% |
Nova Mentis Life Science Corp. | 25.4 Thousand CAD | 203.893% |
PharmaTher Holdings Ltd. | -711.00 CAD | -3612.236% |
PreveCeutical Medical Inc. | -9856.00 CAD | -167.796% |
Telescope Innovations Corp. | 595.39 Thousand CAD | 104.433% |